Sitravatinib (MGCD516)
Catalog No. A16259
Sitravatinib是一种新型小分子抑制剂,靶向多种参与驱动肉瘤细胞生长的RTK。
Catalog Num | A16259 |
---|---|
M. Wt | 629.68 |
Formula | C33H29F2N5O4S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1123837-84-2 |
Synonyms | MGCD516, MG516 |
SMILES | O=C(C1(C(NC2=CC=C(F)C=C2)=O)CC1)NC3=CC=C(OC4=C5C(C=C(C6=NC=C(CNCCOC)C=C6)S5)=NC=C4)C(F)=C3 |
Sitravatinib是一种新型小分子抑制剂,靶向多种参与驱动肉瘤细胞生长的RTK。
In vitro | DMSO | 98 mg/mL (155.63 mM) | |
Water | Insoluble | ||
Ethanol | 98 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 15.88 mL | 79.41 mL | 158.81 mL |
0.5 mM | 3.18 mL | 15.88 mL | 31.76 mL |
1 mM | 1.59 mL | 7.94 mL | 15.88 mL |
5 mM | 0.32 mL | 1.59 mL | 3.18 mL |
*The above data is based on the productmolecular weight 629.68. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.